Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
antifungal medication
|
| gptkbp:ATCCode |
A07AA02
|
| gptkbp:brand |
Mycostatin
Nilstat Nystan |
| gptkbp:CASNumber |
1400-61-9
|
| gptkbp:chemicalFormula |
C47H75NO17
|
| gptkbp:discoveredBy |
gptkb:Rachel_Fuller_Brown
Elizabeth Lee Hazen |
| gptkbp:discoveredIn |
1950
|
| gptkbp:eliminationHalfLife |
not systemically absorbed
|
| gptkbp:firstAntifungalApprovedForHumans |
true
|
| https://www.w3.org/2000/01/rdf-schema#label |
nystatin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
binds to ergosterol in fungal cell membrane
|
| gptkbp:notAbsorbedOrally |
true
|
| gptkbp:pregnancyCategory |
C
|
| gptkbp:producedBy |
Streptomyces noursei
|
| gptkbp:PubChem_CID |
5284447
|
| gptkbp:routeOfAdministration |
oral
topical vaginal |
| gptkbp:sideEffect |
nausea
vomiting diarrhea skin irritation |
| gptkbp:UNII |
8A5I2VNB4I
|
| gptkbp:usedFor |
treatment of candidiasis
treatment of fungal infections |
| gptkbp:WHOModelListOfEssentialMedicines |
true
|
| gptkbp:bfsParent |
gptkb:Candidiasis
|
| gptkbp:bfsLayer |
5
|